News & Updates

During their lifetimes, many women will face a wide array of health issues. Some will seek treatment for gynecological conditions, such as endometriosis and uterine cancer. Others will experience conditions that affect both males and females, but that follow a different course in women, such as heart disease. Women's health is also affected by factors like socioeconomic status and race/ethnicity, sometimes in ways that they cannot control directly.

Asthma is a growing problem in the United States, especially in children. This condition causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, and coughing. Inhaling certain substances or doing certain activities can trigger asthma symptoms. Common asthma triggers include animals, dust, chemicals in the air or in food, exercise, mold, pollen, stress, tobacco smoke, and respiratory infections such as colds.

The newly released 2011 DIR Annual Report reviews the latest basic, clinical, and translational research being pursued by the staff scientists within DIR at the NICHD. Contributing to this effort are 79 tenured and tenure-track investigators and approximately 1,200 administrative and research staff. In 2011, DIR project areas ranged from vaccine development to genomics, from reproduction to regenerative medicine, and from the neurosciences and early human development to biophysics and imaging.

Treatment with vitamin D reduced the size of uterine fibroids in laboratory rats predisposed to developing the benign tumors, reported researchers funded by the National Institutes of Health.

Uterine fibroids are common non-cancerous tumors that affect the majority of American women at some point in their lives. Fibroids may be painful and result in such reproductive problems as infertility, miscarriage, and early labor.

The 2010 DIR Annual Report illustrates the impressive accomplishments that result when dozens of PIs, more than 350 trainees, and approximately 1,200 staff all work toward the same goal of improving human health.

NICHD Director Alan E. Guttmacher, M.D., initiated the NICHD Director’s Lecture Series as a way to showcase cutting-edge science relevant to the Institute’s mission. The forum also enables staff and other attendees to interact with other nationally recognized scientists.

Millions of Americans with reproductive health disorders stand to benefit from new research funded by the National Institutes of Health. With funds from the American Recovery and Reinvestment Act, the National Institutes of Health today announced grants totaling nearly $60 million for research into disorders that impair fertility, cut short a woman's reproductive years, and often cause intense pain.

The Division’s research programs address topics ranging from molecular and cellular biology, genetics, and endocrine and genetic disorders, to physical biology, neurosciences, immunology, reproduction, and behavioral research. Its projects are organized around the theme of the orchestration of life by molecular messengers.

A new study suggests that the conventional hormone therapies used to treat fibroid tumors are unlikely to produce much improvement and at best will only temporarily relieve symptoms. However, the study findings also suggest a strategy for developing a new, non-surgical treatment.

Fibroid tumors-the sometimes painful uterine growths affecting many American women-lack a key protein that plays a role in holding tissues together, according to a study by researchers from the Uniformed Services University of the Health Sciences (USUHS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

Scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the University of South Florida, Tampa, have come one step closer to identifying the cause of uterine fibroids - a condition that affects up to 70 percent of all reproductive age women and can lead to heavy menstrual bleeding, pain, and in some cases, infertility.

Portable monitors that detect contractions of the uterus do not appear to be useful for identifying women likely to have a preterm delivery, according to a study by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

A new study conducted by researchers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network suggests that the steroid dexamethasone, which is commonly prescribed to help premature infants get off mechanical ventilators, may have serious side effects.